1·Objective: To investigate the time window of urokinase thrombolysis.
目的：探讨尿激酶溶栓治疗的时间窗。
2·Streptokinase and urokinase are important in thrombolytics, and asparaginase is used as a cytostatic agent in the treatment of leukemia.
链激酶和尿激酶溶栓是重要的，是天冬酰胺酶在治疗白血病细胞生长剂。
3·Conclusion Thrombolytic therapy of high dose urokinase impact for central retinal artery occlusion is safe and effective, and the result is better than traditional therapy.
结论大剂量尿激酶冲击溶栓治疗视网膜中央动脉阻塞完全有效，其治疗效果大大好于传统治疗方法。
4·ObjectiveTo determine the clinical curative effect and safety of ultra early intravenous thrombolysis with high-dose urokinase in treatment of acute cerebral infarction.
目的探讨大剂量尿激酶超早期静脉溶栓治疗急性脑梗塞的临床疗效及安全性。
5·Conclusion it is effective and safe for the patients with advanced cerebral infarction to get the treatment through intravenous thrombolysis with low-dose urokinase.
结论低剂量尿激酶静脉溶栓治疗进展性脑梗死有效且相对安全。